Funds and ETFs Bristol-Myers Squibb Company

BMY

US1101221083

Name	Weight	AuM	1st Jan change	Investor Rating
RBC QUANT U.S. EQUITY LEADERS ETF - USD	0.78%	3 M€	+15.16%	-
HAMILTON ENHANCED MULTI-SECTOR COVERED CALL ETF - CAD	0.77%	265 M€	+6.12%	-
SPDR STOXX GLOBAL LOW VOLATILITY UCITS ETF (ACC) - USD	0.68%	5 M€	-.--%	-
FIRST TRUST EQUITY COMPASS RISK MANAGER ETF - USD	0.67%	8 M€	+5.48%	-
ANFIELD U.S. EQUITY SECTOR ROTATION ETF - USD	0.66%	85 M€	+13.83%	-
ISHARES ESG MSCI USA LEADERS INDEX ETF - CAD	0.63%	2 M€	+14.69%	-
NEXT FUNDS S&P 500 ESG INDEX EXCHANGE TRADED FUND - JPY	0.62%	26 M€	+21.55%	-
HARTFORD MULTIFACTOR US EQUITY ETF - USD	0.61%	375 M€	+9.35%
FIDELITY U.S. DIVIDEND FOR RISING RATES CURRENCY NEUTRAL INDEX ETF - CAD	0.60%	7 M€	+6.22%	-
GOLDMAN SACHS ACTIVEBETA US LARGE CAP EQUITY UCITS ETFC- USD	0.56%	50 M€	+11.43%
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - EUR	0.55%	264 M€	-.--%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - CHF	0.55%	187 M€	+11.11%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - B - USD	0.55%	477 M€	+12.51%
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - ACC - EUR	0.54%	414 M€	+13.56%	-
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - DIST - EUR	0.54%	1,006 M€	-.--%	-
FIDELITY U.S. VALUE CURRENCY NEUTRAL INDEX ETF - CAD	0.49%	22 M€	+16.35%
OSSIAM BLOOMBERG USA PAB UCITS ETF - 1A - EUR HEDGED	0.49%	8 M€	+7.51%	-
OSSIAM BLOOMBERG USA PAB UCITS ETF - 1A (EUR) - EUR	0.49%	744 M€	+9.63%
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (D) - EUR	0.48%	29 M€	-.--%	-
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (C) - EUR	0.48%	322 M€	+13.88%	-
REVERE SECTOR OPPORTUNITY ETF - USD	0.48%	6 M€	+17.98%	-
V-SHARES US LEADERSHIP DIVERSITY ETF - USD	0.48%	1 M€	+0.04%
AGILITY SHARES MANAGED RISK ETF - USD	0.48%	121 M€	+8.28%	-
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.47%	655 M€	-.--%	-
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DAILY HEDGED TO EUR - ACC - HEDGED EUR	0.47%	273 M€	-.--%
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DIST - USD	0.47%	1,174 M€	+23.54%
AMUNDI S&P 500 ESG UCITS ETF EUR HEDGED ACC - EUR	0.47%	559 M€	+14.30%
AMUNDI S&P 500 ESG UCITS ETF ACC - EUR	0.47%	1,848 M€	+18.39%	-
LYXOR MSCI USA CLIMATE CHANGE UCITS ETF - USD	0.45%	36 M€	+22.19%
VANECK SUSTAINABLE WORLD EQUAL WEIGHT UCITS ETF - EUR	0.45%	727 M€	+9.29%
NEXT FUNDS S&P 500 (UNHEDGED) ETF - JPY	0.43%	57 M€	+21.77%	-
SECTOR ROTATION ETF - USD	0.43%	1,487 M€	+9.08%	-
VANECK MULTI-ASSET GROWTH ALLOCATION UCITS ETF - EUR	0.40%	25 M€	+3.42%	-

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

Pharmaceuticals

Calendar

2024-07-26 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

44.11 USD

Average target price

53.19 USD

Spread / Average Target

+20.60%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BRISTOL-MYERS SQUIBB COMPANY	-14.03%	89.42B
ELI LILLY AND COMPANY	+32.36%	694B
NOVO NORDISK A/S	+29.97%	593B
JOHNSON & JOHNSON	-1.60%	371B
MERCK & CO., INC.	+20.07%	331B
ABBVIE INC.	+6.04%	290B
ASTRAZENECA PLC	+14.43%	239B
NOVARTIS AG	+10.27%	209B
ROCHE HOLDING AG	-3.39%	209B
AMGEN INC.	+9.27%	169B

Other Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2024-05-16 pm EDT			After market 08:00:00 pm
44.11 ^USD	-0.99%		44.59	+1.09%

May. 16	Everlasting momentum
May. 16	Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma	DJ